When should an implantable cardioverter-defibrillator (ICD) be used instead of a pacemaker?

ICD vs Pacemaker: When to Use Each Device

An ICD should be used instead of a pacemaker when the primary goal is prevention of sudden cardiac death from ventricular arrhythmias (ventricular tachycardia or ventricular fibrillation), while a pacemaker alone is appropriate when the sole indication is treatment of bradycardia without significant risk of life-threatening ventricular arrhythmias.

Core Decision Framework

The fundamental distinction is based on arrhythmia type and mortality risk:

Choose an ICD when:

• Primary prevention of sudden cardiac death in patients with reduced ejection fraction (LVEF ≤35%) post-MI or with non-ischemic cardiomyopathy 1
• Secondary prevention after survived sudden cardiac arrest or sustained ventricular tachycardia 1
• High-risk features in adult congenital heart disease (unexplained syncope, frequent PVCs, QRS ≥180ms, severe ventricular dysfunction) 1
• Life-threatening ventricular arrhythmias not due to reversible causes 2

Choose a pacemaker alone when:

• Symptomatic bradycardia (sinus bradycardia, AV block, tachy-brady syndrome) without ventricular arrhythmia risk 3
• No indication for sudden cardiac death prevention
• Normal or near-normal ejection fraction without structural heart disease predisposing to ventricular arrhythmias

Critical Nuance: Combined Needs

If a patient requires BOTH defibrillation capability AND pacing, the approach depends on pacing requirements:

Standard transvenous ICD systems (with pacing capability):

• Use when bradycardia pacing is needed or anticipated 1
• Use when cardiac resynchronization therapy (CRT) is indicated 1
• Use when antitachycardia pacing for VT termination is required 1

Subcutaneous ICD (S-ICD):

• Recommended when ICD indication exists BUT pacing for bradycardia, VT termination, or CRT is neither needed nor anticipated 1
• Particularly useful with inadequate vascular access or high infection risk 1
• Should NOT be implanted if bradycardia pacing or CRT is required 1

Research shows only 5.2% of post-MI patients with reduced EF required pacemaker/CRT implantation over 20 months 3. Predictors of future pacing needs include baseline PR interval >200ms and prior CABG 3.

Common Pitfalls to Avoid

1. Don't implant a pacemaker alone in patients with LVEF ≤35% post-MI or with non-ischemic cardiomyopathy—these patients need ICD protection regardless of bradycardia symptoms

2. Don't choose S-ICD if there's any anticipated need for pacing (even future CRT consideration), as this would require a separate pacemaker implant 4

3. In patients with existing pacemakers who later develop ICD indications, combined systems can be used but require careful mapping to avoid device-device interactions 5

4. Patients with ICDs who need pacing should receive biventricular pacing (CRT), not dual-chamber pacing 2

Special Consideration: Wearable Cardioverter-Defibrillator

For temporary high-risk periods (awaiting transplant, within 40 days post-MI with LVEF ≤35%, newly diagnosed cardiomyopathy, or during ICD removal for infection), a wearable cardioverter-defibrillator may be reasonable as a bridge 1.